This document outlines details of PBS-subsidised anifrolumab for patients with systemic lupus erythematosus (SLE).
For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.
Systemic lupus erythematosus (SLE) quick reference
|
Restrictions |
Authority level and section |
PA assessment |
Processing system |
Prescriber type |
Prescriber self-serve |
|
Initial
PB365 form |
Written
S100:
anifrolumab |
Yes |
OPA |
Must be treated by a:
specialist physician experienced in the management of SLE |
No |
|
Grandfather
PB366 form |
Written
S100:
anifrolumab |
Yes |
OPA |
Must be treated by a:
specialist physician experienced in the management of SLE |
No |
|
Continuing
or
Recommencement (after a break < 12 months) |
Telephone
Electronic
S100:
anifrolumab |
No |
OPA |
Must be treated by a:
specialist physician experienced in the management of SLE |
Yes |
Expand all